Literature DB >> 26823584

Draft Genome Sequence of Klebsiella pneumoniae KGM-IMP216 Harboring blaCTX-M-15, blaDHA-1, blaTEM-1B, blaNDM-1, blaSHV-28, and blaOXA-1, Isolated from a Patient in Lebanon.

Sima Tokajian1, Jonathan A Eisen2, Guillaume Jospin2, Ghassan Matar3, George F Araj4, David A Coil2.   

Abstract

We present the draft genome of highly drug-resistant Klebsiella pneumoniae KGM-IMP216, isolated from a urine sample collected from a patient in Lebanon. The draft genome sequence consisted of 77 contigs, including a combined 5,731,500 bases with 57% G+C content.
Copyright © 2016 Tokajian et al.

Entities:  

Year:  2016        PMID: 26823584      PMCID: PMC4732337          DOI: 10.1128/genomeA.01632-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Klebsiella pneumoniae is among the most important causes of both hospital and community-acquired serious bacterial infections in humans. Extended-spectrum β-lactamase (ESBL)–producing organisms remain important causes of the failure of therapy with cephalosporins and have serious infection-control consequences. Infections due to ESBL-producing K. pneumoniae are most often involved in urinary and respiratory tract infections (1). The ESBL genes are mostly plasmid-encoded (2), and most ESBLs can be divided into three genotypes: TEM, SHV, and CTX-M (3). The emergence of ESBL-producing bacteria is now a critical concern. β-lactamases are able to hydrolyze oxyimino-cephalosporins and aztreonam, and constitute an increasingly important mechanism of antimicrobial resistance among nosocomial Gram-negative pathogens (4). ESBLs of the CTX-M type, with CTX-M-15 being the variant most commonly identified in species of human origin, and the plasmid-encoded AmpC-type β-lactamases (blaDHA) have been recognized to be of growing importance (5). Carbapenems are the primary therapeutic agents for infections caused by ESBLs. The extensive use of carbapenems led to the emergence of isolates with resistance genes coding for carbapenemases (6). Among the clinically significant carbapenemases are class B (NDM-1: New Delhi metallo-β-lactamase-1) and class D (OXA-1) (7). In this study we sequenced K. pneumoniae KGM-IMP216 of multilocus sequence type ST-14 harboring blaCTX-M-15, blaDHA-1, blaTEM-1B, blaNDM-1, blaSHV-28, and blaOXA-1, isolated from a urine sample at the American University of Beirut Medical Center in Lebanon (8–10). A Nextera XT kit (Illumina, San Diego, CA, USA) was used to simultaneously fragment and adapter-tag the library, as per the manufacturer’s instructions. The library was normalized by bead-based affinity and then sequenced using the MiSeq version 3 600-cycle kit (Illumina) to perform 300-bp paired-end sequencing on a MiSeq instrument (Illumina), per the manufacturer’s instructions. Quality trimming and error correction of the reads resulted in 4,192,299 high-quality reads. All sequence processing and assembly was performed using the A5-miseq assembly pipeline. This pipeline automates the processes of data cleaning, error correction, contig assembly, scaffolding, and quality control (11, 12). The initial assembly produced 77 contigs, for which no scaffolding was obtained. The final collection of contigs was submitted to GenBank. The final draft genome sequence consisted of a combined 5,731,500 bases with 57% G+C content. Automated annotation was performed using the RAST annotation server (13). K. pneumoniae KGM-IMP216 contains 5,499 predicted coding sequences and 112 predicted RNAs. Moreover, IncN, IncL/M, IncFII(K), IncFIA(HI1), IncR, and IncFIB(K) plasmid types were detected using the PlasmidFinder version 1.3 web server (https://cge.cbs.dtu.dk/services/PlasmidFinder) (14).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number LJOI00000000. The version described in this paper is the first version, LJOI01000000.
  14 in total

1.  The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology.

Authors:  Rima I El-Herte; Souha S Kanj; Ghassan M Matar; George F Araj
Journal:  J Infect Public Health       Date:  2012-04-10       Impact factor: 3.718

Review 2.  Resistance in gram-negative bacteria: Enterobacteriaceae.

Authors:  David L Paterson
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

3.  A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data.

Authors:  David Coil; Guillaume Jospin; Aaron E Darling
Journal:  Bioinformatics       Date:  2014-10-22       Impact factor: 6.937

4.  Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia.

Authors:  E P Barantsevich; I V Churkina; N E Barantsevich; J Pelkonen; E V Schlyakhto; N Woodford
Journal:  J Antimicrob Chemother       Date:  2013-01-12       Impact factor: 5.790

5.  Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.

Authors:  Tatsuya Nakamura; Masaru Komatsu; Katsutoshi Yamasaki; Saori Fukuda; Yugo Miyamoto; Takeshi Higuchi; Tamotsu Ono; Hisaaki Nishio; Noriyuki Sueyoshi; Kenji Kida; Kaori Satoh; Hirofumi Toda; Masahiro Toyokawa; Isao Nishi; Masako Sakamoto; Masahiro Akagi; Isako Nakai; Tomomi Kofuku; Tamaki Orita; Yasunao Wada; Takuya Zikimoto; Chihiro Koike; Shohiro Kinoshita; Itaru Hirai; Hakuo Takahashi; Nariaki Matsuura; Yoshimasa Yamamoto
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

6.  Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.

Authors:  Rima I El-Herte; George F Araj; Ghassan M Matar; Maysa Baroud; Zeina A Kanafani; Souha S Kanj
Journal:  J Infect Dev Ctries       Date:  2012-05-14       Impact factor: 0.968

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 8.  Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams.

Authors:  G A Jacoby
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982

9.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  2 in total

1.  Genome sequencing and comparative analysis of an NDM-1-producing Klebsiella pneumoniae ST15 isolated from a refugee patient.

Authors:  Tamara Salloum; Harout Arabaghian; Sahar Alousi; Edmond Abboud; Sima Tokajian
Journal:  Pathog Glob Health       Date:  2017-04-11       Impact factor: 2.894

Review 2.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.